3002.41.00.00
Vaccines for human medicine
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified: Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products
Duty rates
Column 1 (General / MFN)
Free
Column 2 (Non-NTR)
Free
The rates above are statutory column rates. Trade remedies in Chapter 99 (Section 301, 232, IEEPA, reciprocal) and FTA preferences can change the duty owed on a given entry — see below.
Trade measures (Chapter 99)
9903.03.01
The duty provided in the applicable subheading + 10%
Except for products described in headings 9903.03.02–9903.03.11, articles the product of any country, as provided for in subdivision (aa) of U.S. note 2 to this subchapter
Effective from February 24, 2026 through July 24, 2026
9903.03.02
The duty provided in the applicable subheading
Articles the product of any country that (1) were loaded onto a vessel at the port of loading and in transit on the final mode of transit prior to entry into the United States, before 12:01 a.m. eastern standard time on February 24, 2026; and (2) are entered for consumption, or withdrawn from warehouse for consumption, before 12:01 a.m. eastern standard time on February 28, 2026
Effective from February 24, 2026 through July 24, 2026
9903.03.03
The duty provided in the applicable subheading
Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Effective from February 24, 2026 through July 24, 2026
9903.03.04
The duty provided in the applicable subheading
Articles the product of any country, as provided for in subdivision (aa)(iii) of U.S. note 2 to this subchapter
Effective from February 24, 2026 through July 24, 2026
9903.03.05
The duty provided in the applicable subheading
Articles of civil aircraft (all aircraft other than military aircraft); their engines, parts and components; their other parts, components and subassemblies; and ground flight simulators and their parts and components of any country, provided for in subdivision (aa)(iv) of U.S. note 2 to this subchapter
Effective from February 24, 2026 through July 24, 2026
9903.03.06
The duty provided in the applicable subheading
Articles of aluminum, of steel, or of copper or derivative aluminum or steel articles; passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans, and cargo vans) and light trucks; parts of passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans, and cargo vans) and light trucks; medium- and heavy-duty vehicles; parts of medium- and heavy-duty vehicles; wood products; and semiconductor articles, of any country, as provided in subdivision (aa)(v) of U.S. note 2 to this subchapter
Effective from February 24, 2026 through July 24, 2026
9903.03.07
The duty provided in the applicable subheading
Articles the product of Canada, as provided for in subdivision (aa)(vi) of U.S. note 2 to this subchapter
Applies to origin: CA
Effective from February 24, 2026 through July 24, 2026
9903.03.08
The duty provided in the applicable subheading
Articles the product of Mexico, as provided for in subdivision (aa)(vii) of U.S. note 2 to this subchapter
Applies to origin: MX
Effective from February 24, 2026 through July 24, 2026
9903.03.09
The duty provided in the applicable subheading
Articles of textiles or apparel the product of Costa Rica, the Dominican Republic, El Salvador, Guatemala, Honduras or Nicaragua, as provided for in subdivision (aa)(viii) of U.S. note 2 to this subchapter
Applies to origin: CR, SV, GT, HN, NI, DO
Effective from February 24, 2026 through July 24, 2026
9903.03.10
The duty provided in the applicable subheading
Articles that are donations, by persons subject to the jurisdiction of the United States, such as food, clothing and medicine, intended to be used to relieve human suffering
Effective from February 24, 2026 through July 24, 2026
9903.03.11
The duty provided in the applicable subheading
Articles that are informational materials, including but not limited to publications, films, posters, phonograph records, photographs, microfilms, microfiche, tapes, compact disks, CD ROMs, artworks and news wire feeds
Applies to origin: IL
Effective from February 24, 2026 through July 24, 2026
Related CBP rulings
The tariff classification of HEC88473 Drug Product (also known as APL-18881) in dosage form, from China
are modified in any way, or if the goods do not conform to these facts at time of importation, you should bring this to the attention of U.S. Customs and Border Protection (CBP) and submit a request for a new ruling in accordance with 19 CF
The tariff classification of Lentiviral Vector from China
Lentiviral vector is derived from a HIV-1 lentivirus that has been modified by removal of viral replication genes including deletions that result in a self-inactivating lentiviral vector. The lentiviral vector is produced in a HEK293T cell
The tariff classification of Poliomyelitis Vaccine inactivated monovalent types 1, 2 and 3 from France
Poliomyelitis Vaccine inactivated monovalent types 1, 2 and 3 are vaccines that protects against the poliovirus and is given to prevent poliomyelitis. In your letter,
The tariff classification of Hyrimoz® (adalimumab-adaz) Injection in dosage form, from Austria
Hyrimoz® (adalimumab-adaz) Injection is a monoclonal anti-tumor necrosis factor alpha antibody. It is used in the treatment of a wide variety of inflammatory conditions such as rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic
The tariff classification of ELOCTATE® [Antihemophilic factor (recombinant), Fc fusion protein] in dosage form, from the United States
ELOCTATE, [Antihemophilic factor (recombinant), Fc fusion protein], is a recombinant DNA derived, antihemophilic factor indicated in adults and children with Hemophilia A (congenital Factor VIII deficiency) for the on-demand treatment and c
The tariff classification of clinical trial kits from the United States
Both products will be imported from Ireland. The first product, MK-5592 clinical trial kit contains Noxafil, a brand name antifungal medication containing Posaconazole, as the active pharmaceutical ingredient (API). The MK-5592 clinical tri
The tariff classification of YESCARTA® (Axicabtagene Ciloleucel) from the Netherlands
YESCARTA® (Axicabtagene Ciloleucel) is a CD19-directed genetically modified autologous T cell immunotherapy. It is indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of sy
Request for Internal Advice on Protest No. 3002-21-103869; U.S. International Trade Commission; General Exclusion Order; Investigation No. 337-TA-567, Certain Foam Footwear
was easily removable, in contravention of the Commission’s finding in the advisory opinion proceeding referenced above. See Comm’n Op. (Advisory Opinion Proceeding 2) at 13. Thus, CBP issued an exclusion letter to Triple T on October 25, 20
The tariff classification of glycerol stock of Escherichia coli (E. coli) from China
The glycerol stock consists of a frozen laboratory strain of Escherichia coli (E. coli) that carries an artificial engineered plasmid consisting of 50 percent glycerol (CAS No. 56-81-5) and 50 percent E. coli bacillus. E. coli is a Gram-neg
The tariff classification of Recombinant Adeno-associated virus (AAV) packed for retail sale from China
The subject product consists of recombinant Adeno-associated virus (AAV) in a buffer solution put up in vials. Adeno-associated virus is a non-enveloped virus with a single-stranded DNA genome and can be engineered to deliver DNA to target
The tariff classification of Recombinant Lentivirus packed for retail sale from China, the United Kingdom and the European Union countries
The subject product consists of recombinant lentivirus in a solution with a buffer and a cryopreservative put up in vials. Lentivirus (LV) is an enveloped retrovirus with a single-stranded RNA genome. In your letter,
The tariff classification of ADSTILADRIN® (nadofaragene firadenovec-nrpl) in dosage form and a demonstration unit for Adstiladrin from Finland
Adstiladrin, imported in 4 x 20 mL single dose vials, is a sterile suspension for intravesical instillation containing nadofaragene firadenovec-nrpl, a non-replicating recombinant type 5 adenovirus vector containing the human interferon alf
Other codes in heading 3002
Duty by origin country
The rate above is the statutory base. Total landed duty depends on origin — see the calculated rate for 3002.41.00.00 from each major US trading partner.
Need to defend this classification?
TariffLens generates GRI reasoning, cites the right CBP rulings, and builds the audit trail you need for reasonable care.
Book a demo →